Point72 Asset Management
ECYT

Point72 Asset Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Point72 Asset Management’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,106,849
Closed -$37.4M – 1349
2018
Q3 		$37.4M Buy
+2,106,849
New +$36.2M 0.15% 185

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Point72 Asset Management's ECYT Position: Q4 2018 in Review

Point72 Asset Management sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 2,106,849 shares — an estimated $37.4M sold.

Point72 Asset Management first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $37.4M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Point72 Asset Management reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Point72 Asset Management sold 2,106,849 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $37.4M.
  • Point72 Asset Management first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Point72 Asset Management's Endocyte, Inc. Common Stock position peaked at $37.4M in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Point72 Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.